Parameter | All patients (n = 155) | Never transfused (n = 59) | Ever transfuseda (n = 71) | P value |
---|---|---|---|---|
Age (years) | 62.3 ± 16.3 | 61.2 ± 18.0 | 62.9 ± 15.8 | 0.56 |
Male (n [%]) | 98 (63%) | 35 (59%) | 50 (70%) | 0.19 |
BMIb (kg/m2) | 26.6 ± 7.3 | 26.6 ± 7.1 | 26.5 ± 7.8 | 0.95 |
Surgical (%) | 64 (41%) | 19 (32%) | 33 (46%) | 0.10 |
APACHE II score | 23.4 ± 8.0 | 20.5 ± 8.9 | 24.4 ± 6.9 | 0.007 |
Admission diagnosis (n [%]) | 0.24c | |||
Respiratory | 58 (37%) | 26 (44%) | 25 (35%) | |
Cardiovascular | 41 (26%) | 14 (24%) | 20 (28%) | |
Gastrointestinal | 32 (21%) | 8 (13%) | 19 (27%) | |
Neurologic | 12 (8%) | 7 (12%) | 4 (6%) | |
Other | 12 (8%) | 4 (7%) | 3 (4%) | |
Comorbidities (n [%]) | ||||
CAD | 37 (24%) | 10 (17%) | 19 (27%) | 0.18 |
CHF | 18 (12%) | 5 (8%) | 9 (13%) | 0.44 |
CVA | 15 (10%) | 7 (12%) | 6 (8%) | 0.52 |
DM | 31 (20%) | 10 (17%) | 16 (23%) | 0.43 |
COPD | 38 (25%) | 15 (25%) | 18 (25%) | 0.99 |
HTN | 41 (26%) | 13 (22%) | 20 (28%) | 0.42 |
Cancer | 19 (12%) | 6 (10%) | 11 (15%) | 0.37 |
ESRD | 7 (5%) | 1 (2%) | 5 (7%) | 0.22c |
Medications (n [%]) | ||||
Erythropoietin | 24 (15%) | 2 (3%) | 16 (23%) | 0.002 |
Iron | 39 (25%) | 9 (15%) | 24 (34%) | 0.016 |
Hemoglobin (g/dl) | ||||
Day 0 | 11.1 ± 2.5 | 11.8 ± 2.5 | 10.8 ± 2.5 | 0.04 |
Day 7 | 9.4 ± 1.4 | 9.8 ± 1.5 | 9.2 ± 1.2 | 0.003 |
Day 14 | 9.0 ± 1.2 | 9.4 ± 1.3 | 8.8 ± 1.0 | 0.002 |
Day 21 | 9.0 ± 1.1 | 9.4 ± 1.2 | 8.8 ± 0.9 | 0.001 |